RenovoRx, Inc. ("RenovoRx" or the "Company") , a life sciences company developing innovative targeted oncology therapies and commercializing RenovoCath®, a novel, FDA-cleared drug-delivery device, ...

GE HealthCare is also using ACC 2025 to highlight new AI-powered innovations for cardiac care: The latest version of CASE (Cardiac Assessment System for Stress Testing), powered by the company’s ...

GE HealthCare (Nasdaq: GEHC) today announced the U.S. launch of Flyrcado™ (flurpiridaz F 18) injection at the 2025 American ...

For decades microtubule-targeting agents (MTAs) have been a cornerstone of cancer treatment regimens and continue to be heavily employed as backbone chemotherapy in combination with new targeted ...

Global High Throughput Screening Market is valued approximately at USD 19.1 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 9.70% over the forecast period 2024-2032.

Read the Market Summary Here:- https://reportocean.com/industry-verticals/sample-request?report_id=bw8530 ...

Circulatory death livers preserved for donation with normothermic machine perfusion had the lowest early allograft dysfunction rate. This method led to the shortest hospital and ICU lengths of stay.

Is there an ideal myocardial perfusion imaging protocol? In order to answer this question and choose a protocol for clinical use, one must understand the characteristics of the available ...

A preservation system, the Organ Care System (OCS; TransMedics) uses normothermic pulsatile perfusion during organ transport for heart transplantation. This system has demonstrated favorable outcomes ...

The World Bank’s new mission is to end extreme poverty and boost shared prosperity on a livable planet. The "Poverty, Prosperity, and Planet. Pathways Out of the Polycrisis" report evaluates progress ...